Sterne Kessler Goldstein Fox

Media + Events

ACI Biotech Patent Conference 2010

11.30.10-12.02.10 Boston

Michele Cimbala will present "Navigating the Intricacies of PTO Patent Practice" at ACI's Biotech Patent Conference in Boston.

Other presentation topics include:

  • How generic companies will implement the now-approved follow-on biologic pathway, including what is patentable, exclusivity, and patent resolution
  • How to draft and protect claims going forward in light of the attacks on the patentability of genes and diagnostic methods in Bilski and Myriad
  • Advanced claim drafting strategies and how to incorporate both the written description and enablement requirements
  • Avoiding inequitable conduct- lessons from Therasense, Inc. v. Becton, Dickinson & Co.
  • How to work the PTO rules and the patent prosecution highway in order to streamline the patent approval process and extend actual patent life
  • Developing global strategies for minimizing risk and maximizing profit while filing and protecting patents abroad.

Click here for more information about this conference.

Related Industries

Related People

(1) Recent Headlines

Monica Riva Talley Joins Sterne, Kessler, Goldstein & Fox

Monica Riva Talley Joins Sterne, Kessler, Goldstein & Fox

09.08.10 Sterne, Kessler, Goldstein & Fox P.L.L.C.

Today we announced the expansion of our Trademark Practice with the addition of Monica Riva Talley, a veteran trademark attorney and law firm partner with more than 14 years of experience.
SKGF Named Finalist for Digital PR Award for The Reexamination Center

SKGF Named Finalist for Digital PR Award for The Reexamination Center

08.13.10 Sterne, Kessler, Goldstein & Fox P.L.L.C.

Sterne, Kessler, Goldstein & Fox has been named a finalist in PR News’ Digital PR Awards program in the Microsite/Custom Site category for The Reexamination Center, the first comprehensive website providing news, events, education, and analysis on all aspects of patent reexaminations.

New U.S. Biosimilar Act has Important Implications for Patent Licensing

New U.S. Biosimilar Act has Important Implications for Patent Licensing

08.04.10 Timothy J. Shea & Christine F. Norris, Sterne, Kessler, Goldstein & Fox P.L.L.C.

Timothy Shea and Christine Norris discuss the ramifications for patent licensing created by the passage of The Biologics Price Competition and Innovation Act, signed into law in March 2010.

Post-Grant Review: How Will It Affect Your (Client's) Business?

Post-Grant Review: How Will It Affect Your (Client's) Business?

08.02.10 Eldora L. Ellison and Byron L. Pickard, Bloomberg Law Reports

As the Congressional term nears its end, both houses continue to consider legislation that, if enacted, will change substantially important features of the current Patent Act.1 Post-grant review.

(2) Upcoming Events

Workshop on Tensor Decompositions and Applications
James Raynolds will present "An Algebraic Approach to Optimizing Tensor Operations in MATLAB (and other production languages interpreted or compiled)".

Media Contact

Erin S. West Communications and Marketing Manager

p 202.772.8878   f 202.371.2540

email